BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 46253)

  • 1. Kinetics and localization of IgE tetanus antibody response in mice immunized by the intratracheal, intraperitoneal and subcutaneous routes.
    Gerbrandy JL; Bienenstock J
    Immunology; 1976 Dec; 31(6):913-9. PubMed ID: 992717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of reaginic antibody production in mice. I. Suppression by antigen of IgE antibody production in vitro.
    Danneman PJ; Michael JG
    J Exp Med; 1977 Dec; 146(6):1534-48. PubMed ID: 562920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hapten specific unresponsiveness in mice. I. Characteristics of unresponsiveness induced by 2,4,6-trinitrobenzene sulphonic acid.
    Huchet R; Grandjon D; Davies AJ
    Immunology; 1979 Mar; 36(3):595-605. PubMed ID: 86508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates.
    Lee WY; Sehon AH
    J Immunol; 1976 Jun; 116(6):1711-8. PubMed ID: 58048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaginic antibody formation in the mouse. V. Adoptive antihapten IgE antibody response of dinitrophenyl-keyhole limpet hemocyanin-primed spleen cells cultured with dinitrophenyl heterologous carrier conjugates.
    Okudaira H; Ishizaka K
    J Immunol; 1975 Feb; 114(2 Pt 1):615-20. PubMed ID: 47357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of reaginic antibody formation. I. Induction of hapten-specific tolerance.
    Lee WY; Sehon AH
    J Immunol; 1975 Feb; 114(2 pt 2):829-36. PubMed ID: 46252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suppression of reaginic antibodies].
    Sehon AH; Lee WY
    Ann Immunol (Paris); 1977; 128(1-2):457-68. PubMed ID: 848899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reaginic antibody formation in the mouse. VII. Induction of suppressor T cells for IgE and IgG antibody responses.
    Takatsu K; Ishizaka K
    J Immunol; 1976 May; 116(5):1257-64. PubMed ID: 1083868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of reaginic antibody formation. II. The use of adoptive transfer system for the study of immunological unresponsiveness.
    Lee WY; Sehon AH
    J Immunol; 1975 Feb; 114(2 pt 2):837-42. PubMed ID: 46253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-dependent suppression of an anti-hapten antibody response.
    Basten A; Miller JF; Johnson P
    Transplant Rev; 1975; 26():130-69. PubMed ID: 52217
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies as regulators of induced biosynthesis of immunoglobulins (review)].
    Prokopenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Oct; 47(10):98-102. PubMed ID: 4101403
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies.
    Kishimoto TK
    Front Immunol; 2020; 11():969. PubMed ID: 32508839
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.